Skip to main content

Table 2 Adjusted relative risks (aRR) of pregnancy complications from any complication, preeclampsia (PE), gestational hypertension (GH), gestational diabetes mellitus (GDM), spontaneous preterm birth (sPTB) and small-for-gestational age (SGA) according to vitamin D status categorised based on standardised quartiles and clinical definitions of vitamin D status

From: Vitamin D levels in an Australian and New Zealand cohort and the association with pregnancy outcome

  

Pregnancy Complications

All women

Any Complication

PE

GH

GDM

sPTB

SGA

n (%)

n (%)

aRR*

(95% CI)

n (%)

aRR*

(95% CI)

n (%)

aRR*

(95% CI)

n (%)

aRR*

(95% CI)

n (%)

aRR*

(95% CI)

n (%)

aRR*

(95% CI)

Standardised Quartiles**

             

 Low

711 (25)

328 (46)

0.95 (0.85, 1.07)

46 (6)

1.02 (0.66, 1.57))

57 (8)

0.97 (0.67, 1.42)

28 (4)

0.79 (0.47, 1.30)

36 (5)

0.83 (0.54, 1.29)

84 (12)

1.02 (0.75, 1.39)

 Low-Moderate

755 (27)

318 (42)

1.00 (0.90, 1.12)

42 (6)

1.07 (0.69, 1.64)

65 (9)

1.06 (0.74, 1.52)

25 (3)

0.67 (0.39, 1.16)

33 (4)

0.87 (0.56, 1.35

72 (10)

0.98 (0.73, 1.32)

 Moderate-High

702 (25)

309 (44)

1.0†

37 (5)

1.0†

50 (7)

1.0†

28 (4)

1.0†

39 (6)

1.0†

81 (12)

1.0†

 High

630 (23)

258 (41)

0.93 (0.82, 1.06)†

35 (6)

1.24 (0.78, 1.96)

40 (6)

0.87 (0.58, 1.30)

10 (2)

0.47 (0.23, 0.96)

30 (5)

0.77 (0.48, 1.25)

60 (10)

0.80 (0.57, 1.11)

Vitamin D Status

             

 <25 nmol/L

99 (4)

51 (52)

1.10 (0.89, 1.36)

8 (8)

1.44 (0.68, 3.03))

6 (6)

0.70 (0.32, 1.52)

5 (5)

0.98 (0.38, 2.52)

7 (7)

1.44 (0.68, 3.04)

13 (13)

1.15 (0.66, 2.01)

 25-50 nmol/L

673 (24)

301 (45)

0.93 (0.83, 1.03)

45 (7)

1.18 (0.80, 1.75)

59 (9)

0.97 (0.71, 1.34)

26 (4)

0.89 (0.54, 1.47)

29 (4)

0.75 (0.48, 1.16)

74 (11)

0.93 (0.69, 1.24)

 >50-75 nmol/L

928 (33)

428 (46)

1.0†

48 (5)

1.0†

80 (9)

1.0†

35 (4)

1.0†

52 (6)

1.0†

107 (12)

1.0†

 >75 nmol/L

1098 (39)

435 (40)

0.95 (0.86, 1.04)

60 (5)

1.28 (0.87, 1.87)

67 (6)

0.82 (0.59, 1.12)†

26 (2)

0.78 (0.48, 1.28)

51 (5)

0.86 (0.59, 1.26)

104 (9)

0.86 (0.67, 1.12)

  1. *Relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non Caucasian vs. Caucasian), smoking status at 15 ± 1 weeks’ gestation (no vs. yes), alcohol consumption at 15 ± 1 weeks’ (no vs yes), recreational walking (1-3×/week and ≥ 4×/week vs. never) and recruitment site (Auckland vs. Adelaide)
  2. **Serum 25(OH)D was standardised for month that serum was sampled based as previously described [34]
  3. †Reference category